The development of porcine epidemic diarrhea virus (PEDV) antibody-based assays is important 25 for detecting infected animals, confirming previous virus exposure, and monitoring sow herd 26 immunity. However, the potential cross-reactivity among porcine coronaviruses is a major 27 concern for the development of pathogen-specific assays. In this study, we used serum samples 28 (n = 792) from pigs of precisely known infection status and a multiplex fluorescent microbead-29 based immunoassay and/or enzyme-linked immunoassay platform to characterize the antibody 30 response against PEDV whole-virus (WV) particles and recombinant polypeptides derived from 31 the four PEDV structural proteins, i.e., spike (S), nucleocapsid (N), membrane (M), and envelope 32 (E). Antibody assay cut-off values were selected to provide 100% diagnostic specificity for each 33 target. The earliest IgG antibody response was observed at days 7-10 post-infection, mainly 34 directed against S1 polypeptides. With the exception of non-reactive protein E, we observed a 35 similar antibody ontogeny and pattern of seroconversion for S1, N, M, and WV antigens. 36
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1. Introduction between TGEV and PEDV (17) . Enteric coronaviruses primarily infect villous enterocytes, 70 causing atrophic enteritis that leads to malabsorptive diarrhea (4, 5, 18) . In general, PEDV and 71 TGEV are considered more virulent than PDCoV, but the three pathogens are clinically and 72 histopathologically indistinguishable (5, 14, 19) . Porcine respiratory coronavirus (PRCV) has a 73 predilection for the respiratory tract, but PRCV is an S gene deletion mutant of TGEV and 74 remains on the list of enteric coronavirus differentials. 75
The differential diagnosis of porcine enteric coronaviruses relies on laboratory direct-76 detection methods, e.g., polymerase chain reaction (PCR) methods, immunohistochemistry, 77 fluorescent in situ hybridization, and direct immunofluorescence in tissues (20) (21) (22) (23) . Antibody-78 based assays play an important role in detecting infection and evaluating immunity, but antibody 79 cross-reactivity between porcine enteric coronaviruses is a major concern. As part of the process 80 of developing PEDV-specific antibody assays, we experimentally inoculated pigs with each of 81 the porcine coronaviruses (PEDV, TGEV, PRCV, and PDCoV) and characterized the antibody 82 response to recombinant polypeptides derived from PEDV structural proteins, and to the intact 83 PEDV virion using a multiplex fluorescent microbead-based immunoassay (FMIA) and a whole-84 virus (WV) ELISA. The final aim of this project was to identify highly sensitive and specific 85 to-finish farm with no previous history of porcine coronavirus infections. The pigs were 93 prescreened for evidence of infection with PEDV, TGEV, PRCV, and PDCoV. Pig fecal swabs 94 were tested by a PEDV N gene-based rRT-PCR (21) and PDCoV M gene-based rRT-PCR (14), 95 while pig fecal and nasal swabs were tested by TGEV (S gene)/PRCV (N gene)-based 96 differential . The pigs' serum samples were tested with the PEDV 97 immunofluorescence assay (IFA) (21), PEDV WV ELISA (24), TGEV/PRCV differential ELISA 98 (Svanova, Sweden), and PDCoV IFA (14) . Animals (n = 72) were randomized into six groups; 99 each group consisted of 12 pigs in one room, with 6 pens per room and 2 pigs per pen. Details 100 related to virus strains and the routes of experimental inoculation are presented in Table 1 . The 101 age-related infectious dose for each virus was previously determined in a pilot study (data not 102 shown). The pigs were closely observed twice daily for clinical signs throughout the study. A 103 total of 792 serum samples were collected from each group on day post-infection (DPI) -7, 0, 3, 104 7, 10, 14, 17, 21, 28, 35, and 42 . Virus shedding within groups and absence of cross-105 contamination between groups during the observation period (-7 to 42 DPI) was confirmed by 106 rRT-PCR, whereas seroconversion within inoculation groups was confirmed by ELISA or IFA 107 (data not shown). At 42 DPI, all pigs were humanely euthanized by penetrating captive bolt 108 (Accles and Shelvoke, Ltd., Sutton Coldfield, UK) followed by exsanguination. 109
Five different polypeptides corresponding to the four PEDV structural proteins (S, N, M, and 110 E) were recombinantly generated; PEDV WV particles were purified from cell culture by 111 electrophoresis (SDS-PAGE). PEDV S1-Fc proteins were enzymatically cleaved by incubation 139 with TEV (20 IU/mg sample) for 3 h at 25°C under endotoxin control, and purified from culture 140 supernatant by protein A chromatography (GE Healthcare, Pittsburgh, PA, USA), and nickel 141 (Ni)-chelating Sepharose Fast Flow (SFF) affinity chromatography (GE Healthcare), according 142 to the manufacturer's instructions. Purified rS1 non S-INDEL (717 aa) and rS1 S-INDEL (714 143 aa) proteins were dialyzed against phosphate-buffered saline (PBS) (10 mM phosphate and 150 144 mM NaCl, pH 7.4) and analyzed by SDS-PAGE and Western blot. 145
Generation of PEDV recombinant nucleocapsid (rN) protein 146
An Escherichia coli (E. coli)-codon optimized consensus version ( Figure 1 ) obtained from a 147 multiple sequence alignment (non S-INDEL, S-INDEL, and CV777 strains) of the full-length 148 PEDV N (1,356 nt) gene (Table 2) was synthesized in vitro (Shanghai Genery Biotech Co., Ltd., 149 Shanghai, China). The gene was amplified using the forward primer (5'-CAT CAT CAT CAT 150 CAT CAT ATG GCA TCT GTT AGC TTT CAG GAT CG-3') and reverse primer (5'-AGA CTG 151 CAG GTC GAC AAG CTT TTA ATT GCC GGT ATC GAA GAT C-3'). The amplicon was 152 cloned into pCold II expression plasmid (Novoprotein Scientific Inc., Shanghai, China), 153 confirmed by sequencing (Genewiz Inc., Suzhou, China), and then transformed into the E. coli 154 BL21 (DE3) host strain (Invitrogen TM , Carlsbad, CA, USA). The transformants were 155 resuspended and grown in 1 liter of Luria-Bertani (LB) medium (Invitrogen TM ) containing 100 156 µg/ml ampicillin, at 16°C by shaking at 250 rpm. When an A 600 of 0.9 was reached, 0.1 mM The crude extracts were centrifuged at 15,000 ×g for 30 min at 4°C and the soluble expression of 162 histidine (his)-tag fused N-PEDV protein (50.4 kDa) was confirmed by SDS-PAGE analysis. The 163 rN protein (452 aa) was purified from the soluble fraction by Ni-chelating SFF affinity 164 chromatography (GE Healthcare) according to the manufacturer's instructions. After separation 165 of thrombin cleavage products on the Ni 2+ column, HiTrap TM Phenyl High Performance (HP) 166 (GE Healthcare) hydrophobic interaction chromatography followed by a HiTrap TM SulfoPropyl 167 (SP) HP strong cation exchange chromatography (GE Healthcare) were consecutively applied 168 according to the manufacturer's instructions. Protein elutions were pooled, dialyzed against PBS, 169 pH 7.4, at 4 °C, and analyzed by SDS-PAGE and Western blot. 
Generation of recombinant envelope (rE) small membrane protein 185
A commercial E. coli-expressed PEDV (strain CV777) recombinant his-tagged E protein (76 186 aa) was purchased from Cusabio (CSB-EP771125PPW; Cusabio Biotech Co., MD, USA) and it 187 sequence is presented in Figure 1 . 188 2.6. PEDV multiplex fluorescent microbead-based immunoassay (FMIA) 189
The covalent coupling of purified PEDV WV antigen and recombinant polypeptides to 190 microbead sets was performed as previously described (25 Institute, Inc., Cary, NC, USA). One-way ANOVA with Tukey's correction was used for multiple 228 comparisons with alpha=0.05 (GraphPad Prism® 6). Specifically, we compare the antibody 229 response between inoculation groups by day post inoculation for each antigen target. Figure 4A ). In the PEDV-inoculated group, similar antibody 237 dynamics against rS1s, rN, rM, and WV antigens were observed, with significantly higher 238 (p<0.05) antibody levels than the negative control group at DPI ≥10. Likewise, antibody 239 responses against rS1s (FMIA), rN (FMIA), and WV (ELISA) in the PEDV-inoculated group 240 were significantly higher (p < 0.05) at DPI ≥10 than the TGEV, PRCV, and PDCoV inoculation 241 groups. For rM protein, there were significant differences (p < 0.05) between the PEDV and 242
PDCoV inoculation groups; however, no significant differences in rM response were found in 243 pairwise comparisons between the following treatment groups: PEDV vs TGEV Miller (over 244 time), PEDV vs TGEV Purdue (DPI -7 to 10 and DPI 28 to 42), and PEDV vs PRCV (DPI -7 to 245 10 and DPI 42). No differences in the FMIA IgG S/P ratio antibody response to S1 from the S-246 INDEL strain compared to S1 from the non S-INDEL strain were observed over time in any 247 inoculation group. 248
Diagnostic sensitivity and specificity of PEDV antigens 249
The optimal S/P cut-off points were selected to ensure 100% diagnostic specificity. Selected 250 cut-off values and diagnostic sensitivity associated for each target tested by FMIA (rS1 non S-251 INDEL, rS1 S-INDEL, rN, rM, rE, and WV) or ELISA (WV) is presented in Table 1 . seropositivity using the WV antigen was higher when it was used on the ELISA platform as 261 opposed to the FMIA platform. 262
Cross-reactivity of PEDV antigens against PEDV-related porcine enteric coronaviruses 263
The cumulative distribution of serum antibody responses (S/P) against specific PEDV 264 markers is given in Figure 3 The comparison of the amino acid sequence homology of the 5 purified PEDV polypeptides 280 recombinantly generated (i.e., S1 non S-INDEL and S-INDEL, N, M, and E) with the 281 homologous regions corresponded to porcine coronaviruses PEDV, TGEV Miller, TGEV Purdue, 282 PRCV, and PDCoV used during experimental inoculation is presented in Table 3 . 283 284
Discussion 285
The pig immune system has the ability to recognize specific PEDV proteins and to 286 respond by producing specific antibodies (21, 24, (26) (27) (28) terminal intravirion topological domain of the M protein, previously identified as the major 293 immunodominant region in the M protein, was selected (29). PEDV S protein can be structurally 294 or functionally divided into two subunits: S1 (N-terminal globular head), which binds to the host 295 cell receptors, and S2 (C-terminal membrane-bound stalk), which is responsible for membrane 296 fusion (30, 31). The S1 subunit was selected because it contains major antigenic sites and 297 antiviral neutralizing determinants in many animal coronaviruses, including TGEV (32, 33). 298
However, S1 diverges in sequence even among species of a single coronavirus, thereby 299 contributing to the broad host range of coronaviruses, whereas the S2 subunit is the most 300 on February 17, 2017 by UNIV OF CALIF SAN DIEGO http://jcm.asm.org/ Downloaded from conserved region of the protein (34, 35) . Therefore, two recombinant S1 proteins derived from 301 PEDV non S-INDEL and S-INDEL strains, respectively, were generated and comparatively 302 evaluated. 303
The analysis showed that serum antibody from PEDV-inoculated pigs reacted to all 304 proteins evaluated, except rE. These data are in agreement with previous results on the utility of 305 N (26), S (28), M (27), and WV antigen (24) for PEDV antibody detection. In general, the 306 magnitude of an antibody response is dependent upon the amount of antigen presented to the 307 immune system. The M protein is the most abundant protein in the virion envelope (36), the N 308 protein is the most abundant coronavirus antigen produced throughout infection (37), and the S 309 protein forms the crown-like projection of the viral surface (38). In contrast, E protein is present 310 only in small amounts in infected cells and the viral envelope (39); which may explain its poor 311 antigenicity. 312 A difference in the WV antibody response was noted between the FMIA and ELISA 313 formats. The lower response in the FMIA assay can be attributed to the fact that the Luminex® 314 carboxylated magnetic microbeads bind WV (intact) PEDV particles less efficiently than they 315 bind proteins or polypeptides with free amino groups. Likewise, the highly charged polystyrene 316 microwells utilized on the ELISA platform bind WV PEDV particles most efficiently, providing 317 better detection. 318 PEDV IgG antibodies against S1 (S-INDEL and non S-INDEL), N, M, and WV were 319 first detected between 7 to 10 DPI and thereafter for the duration of the study. However, our data 320 confirmed the antibody response to S1 proteins as the most sensitive marker of early PEDV 321 infection and the best choice for reliable detection of weak seroresponders (Table 2) confirmed that the high percentage of homology in the amino acid sequence of S1 protein among 328 PEDV non-S INDEL and S-INDEL strains (>90%) assures that S1 could be used as a diagnostic 329 marker for a wide range of PEDV strains. 330
In the field, pigs are exposed to different coronaviruses that are known to share genetic 331 and antigenic traits that may contribute to false-positive results. Recent evidence suggesting 332 antibody cross-reactivity between PEDV and TGEV (13) and between PEDV and PDCoV (41) 333 raised concerns about the specificity of PEDV serologic testing using assays based on targets 334 containing the most conserved regions (e.g., N, M, and WV). Therefore, the serologic cross-335 reactivity between individual PEDV antigens and other swine coronaviruses was evaluated by 336 testing antisera from pigs experimentally inoculated with TGEV (Miller and Purdue strains), 337
PDCoV, and PRCV using 6-plex FMIA and WV ELISA. 338
The S1-derived antigens proved to be the best candidate for antibody-based differential 339 testing of porcine coronaviruses based on a complete absence of detectable cross reactivity 340 (100% analytical specificity). Protein N showed some cross-reactivity (2/12 pigs) against TGEV 341
Miller, but not against TGEV Purdue antisera, and only at the early stages post-infection (DPI 7 342 to 14). This "transient" cross-reactivity may explain why it has been reported infrequently. In 343 contrast, PEDV M protein showed the highest percentage of homology with other porcine 344 coronaviruses (Table 4) and should be ruled out as a marker for differential diagnosis, as it was 345 highly cross-reactive against TGEV strains and PRCV. 346
on February 17, 2017 by UNIV OF CALIF SAN DIEGO http://jcm.asm.org/ Downloaded from Differences in cross-reactivity among TGEV strains cannot be explained simply on the 347 basis of amino acid sequence homology (Table 3) We also successfully identified targets of interest (e.g., S1) for the diagnosis of PEDV, providing 361 a truly molecular immunological view of antigenic distribution and a complete antibody cross-362 reactivity profile between PEDV and other porcine enteric coronaviruses. collected at 0, 3, 7, 10, 14, 17, 21, 28, 35, and 42 
